Journal of Gastroenterology and Digestive Diseases

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (629)348-3199

Rapid Communication - Journal of Gastroenterology and Digestive Diseases (2024) Volume 9, Issue 4

The Gut-Brain Axis: How Microbiota Affects Obesity-Related Behaviors

Jamie Fleur *

Department of Medical and Surgical Sciences, University of Bologna, Italy

*Corresponding Author:
Jamie Fleur
Department of Medical and Surgical Sciences, University of Bologna, Italy
E-mail: jfleur@bu.itl.edu.in

Received: 27-Jun-2024, Manuscript No. JGDD-24-142701; Editor assigned: 28-Jun-2024, PreQC No. JGDD-24-142701 (PQ); Reviewed: 12-Jul-2024, QC No. JGDD-24-142701; Revised: 17-Jul-2024, Manuscript No. JGDD-24-142701(R); Published: 24-Jul-2024, DOI: 10.35841/jgdd-9.4.216

Citation: : Fleur J. The Gut-Brain Axis: How Microbiota Affects Obesity-Related Behaviors. J Gastroenterol Dig Dis.2024;9(4):216

Visit for more related articles at Journal of Gastroenterology and Digestive Diseases

Introduction

The gut-brain axis refers to the complex bidirectional communication network that links the gastrointestinal tract and the central nervous system. This intricate system involves neural, hormonal, and immune pathways, with the gut microbiota playing a crucial role. Recent research has shown that gut microbiota can significantly influence brain function and behavior, particularly in relation to obesity-related behaviors. Understanding this connection provides new insights into the mechanisms of obesity and potential therapeutic approaches [1].

The gut microbiota consists of trillions of microorganisms that reside in the gastrointestinal tract. These microorganisms are involved in various physiological processes, including digestion, metabolism, and immune function. Importantly, they also produce a range of metabolites and signaling molecules that can affect the brain. The vagus nerve, a major component of the autonomic nervous system, acts as a critical communication pathway between the gut and the brain, transmitting signals from the gut microbiota to the brain. Additionally, the gut microbiota can influence brain function through the production of neurotransmitters, such as serotonin, which are essential for mood regulation and cognitive function [2, 3].

Obesity is a multifaceted condition influenced by genetic, environmental, and behavioral factors. Recent studies have highlighted the significant role of gut microbiota in modulating behaviors related to food intake and energy balance. One way gut microbiota affects these behaviors is through the production of short-chain fatty acids (SCFAs) like acetate, propionate, and butyrate. These metabolites are produced by the fermentation of dietary fibers by gut bacteria and can influence appetite regulation and energy homeostasis. For instance, propionate has been shown to stimulate the release of peptide YY (PYY) and glucagon-like peptide-1 (GLP-1), hormones that promote satiety and reduce food intake [4, 5].

Moreover, gut microbiota can modulate the expression of genes involved in lipid metabolism and adiposity. Research has demonstrated that certain bacterial species can influence the body's ability to store fat and regulate energy expenditure. For example, a higher ratio of Firmicutes to Bacteroidetes has been associated with increased energy extraction from food and greater fat accumulation, which can contribute to obesity. Additionally, gut microbiota can affect the permeability of the gut barrier, leading to the release of lipopolysaccharides (LPS) into the bloodstream. LPS can trigger systemic inflammation, which is linked to insulin resistance and other metabolic disorders commonly associated with obesity [6].

The gut-brain axis also plays a role in stress and anxiety, which can impact eating behaviors and contribute to obesity. Stress can alter gut microbiota composition, leading to dysbiosis, an imbalance in the microbial community. Dysbiosis can, in turn, affect the production of neurotransmitters and other signaling molecules that influence mood and behavior. For example, reduced levels of beneficial bacteria like Lactobacillus and Bifidobacterium have been associated with increased anxiety and depression. These mood disorders can drive emotional eating and cravings for high-calorie, palatable foods, further exacerbating weight gain and obesity [7].

Dietary interventions aimed at modulating gut microbiota offer promising strategies for addressing obesity-related behaviors. Probiotics and prebiotics are two such interventions that have shown potential in influencing the gut-brain axis. Probiotics are live microorganisms that confer health benefits when consumed in adequate amounts, while prebiotics are non-digestible food components that selectively stimulate the growth of beneficial gut bacteria. Studies have indicated that probiotics like Lactobacillus rhamnosus and Bifidobacterium longum can reduce anxiety and depressive-like behaviors, potentially mitigating stress-induced eating. Prebiotics, such as inulin and fructooligosaccharides, can increase the production of SCFAs and improve gut barrier integrity, contributing to better metabolic health and weight management [8].

Another approach involves dietary polyphenols, naturally occurring compounds found in fruits, vegetables, tea, and wine. Polyphenols exhibit prebiotic-like effects by promoting the growth of beneficial gut bacteria and inhibiting the growth of pathogenic bacteria. For instance, polyphenols from green tea have been shown to increase the abundance of Bifidobacterium and Lactobacillus, which can help restore a healthy gut microbiota balance and improve metabolic outcomes. Additionally, polyphenols can cross the blood-brain barrier and exert neuroprotective effects, potentially influencing mood and behaviour [9].

Fecal microbiota transplantation (FMT) is an emerging intervention that involves transferring gut microbiota from a healthy donor to an individual with obesity. This technique aims to restore a balanced and diverse microbial community in the recipient's gut. Preliminary studies have shown that FMT can lead to improvements in metabolic parameters and weight loss, suggesting its potential as a therapeutic option for obesity. However, more research is needed to fully understand the long-term effects and safety of FMT in obesity treatment [10].

Conclusion

The gut-brain axis represents a complex and dynamic communication network that plays a significant role in obesity-related behaviors. Gut microbiota can influence appetite regulation, energy balance, mood, and stress responses, all of which are critical factors in the development and progression of obesity. Dietary interventions, such as probiotics, prebiotics, and polyphenols, offer promising strategies for modulating the gut-brain axis and addressing obesity-related behaviors. Additionally, fecal microbiota transplantation presents a potential therapeutic approach, though further research is necessary to fully understand its implications. By exploring and harnessing the power of the gut-brain axis, we can develop more effective and holistic strategies for combating obesity and improving overall health.

References

  1. Torres-Fuentes C, Schellekens H, Dinan TG, et al. The microbiota–gut–brain axis in obesity. Lancet Gastroenterol Hepatol. 2017;2(10):747-56.

    2. Indexed at, Google Scholar, Cross Ref

  2. Song X, Wang L, Liu Y, et al. The gut microbiota–brain axis: Role of the gut microbial metabolites of dietary food in obesity. Food Res Int. 2022;153:110971.

    3. Indexed at, Google Scholar, Cross Ref

  3. Burokas A, Moloney RD, Dinan TG, et al. Microbiota regulation of the mammalian gut–brain axis. Adv Appl Microbiol. 2015;91:1-62.

    4. Indexed at, Google Scholar, Cross Ref

  4. Choi BS, Daoust L, Pilon G, et al. Potential therapeutic applications of the gut microbiome in obesity: From brain function to body detoxification. Int J Obes (Lond). 2020;44(9):1818-31.

    5. Indexed at,Google Scholar, Cross Ref

  5. Guerrero-Hreins E, Foldi CJ, Oldfield BJ, et al. Gut-brain mechanisms underlying changes in disordered eating behaviour after bariatric surgery: a review. Rev Endocr Metab Disord. 2022;23(4):733-51.

    6. Indexed at, Google Scholar, Cross Ref

  6. Wang D, Wang L, Han L, et al. Leucine-Restricted Diet Ameliorates Obesity-Linked Cognitive Deficits: Involvement of the Microbiota–Gut–Brain Axis. J Agric Food Chem. 2023;71(24):9404-18.

    7. Indexed at, Google Scholar, Cross Ref

  7. Duan C, Huang L, Zhang C, et al. Gut commensal-derived butyrate reverses obesity-induced social deficits and anxiety-like behaviors via regulation of microglial homeostasis. Eur J Pharmaco. 2021;908:174338.

    8. Indexed at, Google Scholar, Cross Ref

  8. Kim N, Lee J, Song HS, et al. Kimchi intake alleviates obesity-induced neuroinflammation by modulating the gut-brain axis. Food Res Int. 2022;158:111533.

    9. Indexed at, Google Scholar, Cross Ref

  9. Sound R. The gut microbiota–brain axis and role of probiotics. NBHB. 2021:175-191.

    10. Google Scholar

  10. Sood R, Ravichandran S, Gupta A. An Investigation of Brain-Gut-Microbiome Interactions in Food Addiction and Obesity. FACH. 2024:165.

    11. Google Scholar

Get the App